Observational Assessment of Skin Appearance Changes During PRX S Cosmetic Treatment in Participants With Acne-Prone Skin

What is being studied?

Conditions

Acne-prone Skin, Skin Disease

Study type

Interventional

Purpose

Treatment

Phase

NA

How is the study designed?

Enrollment

30 (estimated)

Group design

Single group

Allocation

Not applicable

Masking

None

Minimum age

18 Years

Eligibility sex

All

Which interventions are listed?

• Other: PRX S topical cosmetic treatment
• Other: WiQo home care regimen (Nourishing Cream; Balancing Cream)

What will the study measure?

• Change in VISIA Pores Score Assessment window: Baseline (T0, Week 0), mid-cycle (T1, Week 6), end of follow-up (T2, Week 10)
• Change in VISIA Spots Score Assessment window: Baseline (T0, Week 0), mid-cycle (T1, Week 6), end of follow-up (T2, Week 10)
• Change in VISIA Red Areas Score Assessment window: Baseline (T0, Week 0), mid-cycle (T1, Week 6), end of follow-up (T2, Week 10)
• Change in VISIA Porphyrins Score Assessment window: Baseline (T0, Week 0), mid-cycle (T1, Week 6), end of follow-up (T2, Week 10)
• Change in VISIA Texture Score Assessment window: Baseline (T0, Week 0), mid-cycle (T1, Week 6), end of follow-up (T2, Week 10)

What can this record establish?

These are registered plans and status information. Enrollment marked estimated is a target, not a verified count of participants already studied. The measures listed do not establish that an intervention succeeded. Eligibility criteria and recruitment status must be checked against the full study record before considering participation.